Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Pour

Showing results (51-60 of 108) with videos related to

Pageof 11
Sort By:
Neoplasma|November 10, 2009
Pretreatment hepatocyte growth factor and thrombospondin-1 levels predict response to high-dose chemotherapy for multiple myelomaL Pour, H Svachova, Z Adam, et al.
Neoplasma|April 12, 2012
Efficacy and safety of Id-protein-loaded dendritic cell vaccine in patients with multiple myeloma--phase II study resultsL Zahradova, K Mollova, D Ocadlikova, et al.
Vnitrni Lekarstvi|August 5, 2010
[Different courses of recurrent or multisystem Langerhans cells histiocytosis in adults--description of 22 cases from one centre]Z Adam, M Krejcí, L Pour, et al.
Vnitrni Lekarstvi|May 26, 2006
[The value of fluorodeoxyglucose positron emission tomography in multiple myeloma]Z Adam, K Bolcák, J Stanícek, et al.
Vnitrni Lekarstvi|August 24, 2012
[Cladribine is highly effective in the treatment of Langerhans cell histiocytosis and rare histiocytic disorders of the juvenile xanthogranuloma group]Z Adam, P Szturz, L Pour, et al.
Vnitrni Lekarstvi|December 19, 2009
[Complete remission of nephrotic syndrome and improvement of renal function in a patient with light chain deposition disease following high dose chemotherapy with transplantation of autologous haematopoietic stem cells. A case study and review of literature]Z Adam, M Krejcí, L Pour, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|July 3, 2024
Overview of histiocytic and dendritic disorders by the 5th version of WHO Classifi cation of Hematolymphoid Tumours from 2022Z Adam, M Hermanová, T Horváth, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|May 30, 2018
[MicroRNA Analysis for Extramedullary Multiple Myeloma Relapse]J Gregorová, D Vrábel, L Radová, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|August 28, 2012
[Treatment of Langerhans cells histiocytosis by cladribin reached long-term complete remission in 9 out of 10 adult patients]Z Adam, P Szturz, J Duraš, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|January 9, 2024
Therapy of Castleman's disease with siltuximab - case report and review of literatureZ Adam, D Zeman, A Chodacki, et al.
Pageof 11

Showing results (51-60 of 108) with videos related to

Sort By:
Pageof 11
Neoplasma|November 10, 2009
Pretreatment hepatocyte growth factor and thrombospondin-1 levels predict response to high-dose chemotherapy for multiple myelomaL Pour, H Svachova, Z Adam, et al.
Neoplasma|April 12, 2012
Efficacy and safety of Id-protein-loaded dendritic cell vaccine in patients with multiple myeloma--phase II study resultsL Zahradova, K Mollova, D Ocadlikova, et al.
Vnitrni Lekarstvi|August 5, 2010
[Different courses of recurrent or multisystem Langerhans cells histiocytosis in adults--description of 22 cases from one centre]Z Adam, M Krejcí, L Pour, et al.
Vnitrni Lekarstvi|May 26, 2006
[The value of fluorodeoxyglucose positron emission tomography in multiple myeloma]Z Adam, K Bolcák, J Stanícek, et al.
Vnitrni Lekarstvi|August 24, 2012
[Cladribine is highly effective in the treatment of Langerhans cell histiocytosis and rare histiocytic disorders of the juvenile xanthogranuloma group]Z Adam, P Szturz, L Pour, et al.
Vnitrni Lekarstvi|December 19, 2009
[Complete remission of nephrotic syndrome and improvement of renal function in a patient with light chain deposition disease following high dose chemotherapy with transplantation of autologous haematopoietic stem cells. A case study and review of literature]Z Adam, M Krejcí, L Pour, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|July 3, 2024
Overview of histiocytic and dendritic disorders by the 5th version of WHO Classifi cation of Hematolymphoid Tumours from 2022Z Adam, M Hermanová, T Horváth, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|May 30, 2018
[MicroRNA Analysis for Extramedullary Multiple Myeloma Relapse]J Gregorová, D Vrábel, L Radová, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|August 28, 2012
[Treatment of Langerhans cells histiocytosis by cladribin reached long-term complete remission in 9 out of 10 adult patients]Z Adam, P Szturz, J Duraš, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|January 9, 2024
Therapy of Castleman's disease with siltuximab - case report and review of literatureZ Adam, D Zeman, A Chodacki, et al.
Pageof 11